The manager of RTW Biotech Opportunities has led a $400m Series A financing round for a new portfolio company, Kailera Therapeutics. The announcement does not disclose how much of that came from the listed fund. RTW Investments co-led the Series A with Atlas Venture and Bain Capital Life Sciences, with participation from Lyra Capital. The … Continue reading RTW backs obesity drug firm